For Medical Professionals

Industry News

Kidneys' circadian clock regulates drug disposition, blood component levels
4/08/2016

The kidneys contain a circadian clock that plays a key role in levels of certain blood components - such as lipids and amino acids - as well as drug deposition, finds a new study.

Scientists identify possible double whammy to attack leukaemia
4/07/2016

Manchester scientists have identified a potential double drug combination against B-cell acute lymphoblastic leukaemia, according to a study published in the journal Cell Death and Disease.

Is there association between MC1R & melanoma risk after controlling for sun?
4/07/2016

There is a well-described association between UV radiation exposure from the sun and the development of melanoma.

Novartis receives EU approval for Revolade as first-in-class therapy for children aged 1 year and above with chronic ITP
4/07/2016

Novartis has announced that the European Commission (EC) has approved Revolade®(eltrombopag) for the treatment of pediatric (aged 1 year and above) chronic immune (idiopathic) thrombocytopenic...

The health hazards of space travel
4/07/2016

As the opportunity for space travel comes closer and astronauts start thinking about visits to Mars, we ask: what are the health risks of space travel?

Shortened RT schedule benefits low-risk prostate cancer patients
4/07/2016

The treatment of men with low-risk prostate cancer using a shortened radiotherapy schedule has similar efficacy as treatment with the longer conventional radiotherapy schedule.

New research suggests that early life factors could increase prostate cancer risk
4/07/2016

Factors that influence when boys go through puberty could affect a man's future risk of developing prostate cancer, a large study funded by World Cancer Research Fund has found1.

Radiation therapy chemotherapy combination improves survival in adults with low-grade brain cancer
4/07/2016

Patients with a low-grade type of brain tumor called glioma who received radiation therapy plus a chemotherapy regimen, including procarbazine, lomustine and vincristine (PCV), experienced a longer...

Magnetic delivery of therapeutic enzymes paves the way for targeted thrombosis treatment
4/07/2016

Researchers from ITMO University, the Hebrew University of Jerusalem and Cyril and Methodius University in Skopje have fabricated a new magnetically controlled material composed of enzymes...

How a metabolic pathway promotes breast cancer metastasis
4/07/2016

A metabolic pathway that is up-regulated in certain breast cancers promotes the disease's progression by activating a cell signaling protein called Arf6, according to a paper published in the...